News
BIO
471.97
+0.21%
0.97
BIO Crosses Below Key Moving Average Level
NASDAQ · 6d ago
Is Bristol Myers Squibb Stock A Better Pick Over Its Industry Peer?
NASDAQ · 03/23 03:37
Select Medical's (SEM) Orlando Facility to Boost Post-Acute Care
NASDAQ · 03/21 15:52
SurModics (SRDX) Moves 5.4% Higher: Will This Strength Last?
NASDAQ · 03/17 12:38
Here's Why You Should Retain Acadia (ACHC) in Your Portfolio
NASDAQ · 03/15 15:07
Guru Fundamental Report for BIO - Benjamin Graham
NASDAQ · 03/12 15:11
Wall Street Analysts Predict a 28.56% Upside in Bio-Rad (BIO): Here's What You Should Know
NASDAQ · 03/10 14:55
Golden Cross Appears Before Bio-Rad Laboratories Investors
Benzinga · 03/10 14:48
Is BridgeBio Pharma (BBIO) Stock Outpacing Its Medical Peers This Year?
NASDAQ · 03/10 14:40
Thursday Sector Leaders: Utilities, Healthcare
NASDAQ · 03/09 19:48
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bio-Rad Laboratories (BIO) and Zimmer Biomet Holdings (ZBH)
TipRanks · 03/09 13:40
Bio-Rad (BIO) Global Expansion Strong, FX Woe Dents Growth
NASDAQ · 03/09 12:42
BD (BDX) Boosts Molecular Diagnostics Portfolio With New Tests
NASDAQ · 03/07 15:15
Does Bristol Myers Squibb Stock Have More Room For Growth?
NASDAQ · 03/03 04:11
Analysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA), Moderna (MRNA) and Bio-Rad Laboratories (BIO)
TipRanks · 02/24 13:50
Notable Friday Option Activity: BIO, CRM, V
NASDAQ · 02/17 18:29
Research Alert: CFRA Keeps Buys Opinion On Shares Of Bio-rad Laboratories, Inc.
Research Alert: CFRA Keeps Buys Opinion On Shares Of Bio-rad Laboratories, Inc.
MT Newswires · 02/17 17:13
S&P 500 Analyst Moves: BIO
NASDAQ · 02/17 17:02
Analysts Have Conflicting Sentiments on These Healthcare Companies: Bio-Rad Laboratories (BIO), Shockwave Medical (SWAV) and Regeneron (REGN)
TipRanks · 02/17 16:31
Bio-Rad Laboratories (BIO) Shares Cross Above 200 DMA
NASDAQ · 02/17 15:54
More
Webull provides a variety of real-time BIO stock news. You can receive the latest news about Bio Rad Labs Inc through multiple platforms. This information may help you make smarter investment decisions.
About BIO
Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets a portfolio of various products that serves a global customer base. The segment is focused on specific segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology and food safety. Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market.